Phathom Pharmaceuticals, Inc. PHAT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s net change in cash?
- Phathom Pharmaceuticals, Inc. (PHAT) reported net change in cash of $50.93M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s net change in cash increased by 160.0% year-over-year, from -$84.95M to $50.93M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.